170 related articles for article (PubMed ID: 22248840)
1. Using atosiban in uterine contractions of early pregnancies after assisted reproduction.
Wu MY; Chen SU; Yang YS
J Formos Med Assoc; 2011 Dec; 110(12):800. PubMed ID: 22248840
[No Abstract] [Full Text] [Related]
2. Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour.
Nisell H; Wolff K
BJOG; 2003 Jan; 110(1):89. PubMed ID: 12504956
[No Abstract] [Full Text] [Related]
3. Randomized trial of oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of spontaneous preterm labor in Taiwanese women.
Lin CH; Lin SY; Shyu MK; Chen SU; Lee CN
J Formos Med Assoc; 2009 Jun; 108(6):493-501. PubMed ID: 19515630
[TBL] [Abstract][Full Text] [Related]
4. The oxytocin antagonist atosiban versus the beta-agonist terbutaline in the treatment of preterm labor. A randomized, double-blind, controlled study.
European Atosiban Study Group
Acta Obstet Gynecol Scand; 2001 May; 80(5):413-22. PubMed ID: 11328217
[TBL] [Abstract][Full Text] [Related]
5. Atosiban.
Shubert PJ
Clin Obstet Gynecol; 1995 Dec; 38(4):722-4. PubMed ID: 8616970
[TBL] [Abstract][Full Text] [Related]
6. Treatment of preterm labor with the oxytocin antagonist atosiban: a double-blind, randomized, controlled comparison with salbutamol.
French/Australian Atosiban Investigators Group
Eur J Obstet Gynecol Reprod Biol; 2001 Oct; 98(2):177-85. PubMed ID: 11574128
[TBL] [Abstract][Full Text] [Related]
7. The choice of a tocolytic for the treatment of preterm labor: a critical evaluation of nifedipine versus atosiban.
Lyndrup J; Lamont RF
Expert Opin Investig Drugs; 2007 Jun; 16(6):843-53. PubMed ID: 17501696
[TBL] [Abstract][Full Text] [Related]
8. The effect of the oxytocin antagonist atosiban on preterm uterine activity in the human.
Goodwin TM; Paul R; Silver H; Spellacy W; Parsons M; Chez R; Hayashi R; Valenzuela G; Creasy GW; Merriman R
Am J Obstet Gynecol; 1994 Feb; 170(2):474-8. PubMed ID: 8116700
[TBL] [Abstract][Full Text] [Related]
9. Atosiban for preterm labour.
Tsatsaris V; Carbonne B; Cabrol D
Drugs; 2004; 64(4):375-82. PubMed ID: 14969573
[TBL] [Abstract][Full Text] [Related]
10. Oxytocin, its antagonist Atosiban, and preterm labor: a role for placental nitric oxide.
Nanetti L; Raffaelli F; Giulietti A; Sforza G; Raffaele Giannubilo S; Ciavattini A; Tranquilli AL; Mazzanti L; Vignini A
J Matern Fetal Neonatal Med; 2015 Mar; 28(5):611-6. PubMed ID: 24920283
[TBL] [Abstract][Full Text] [Related]
11. Maintenance treatment of preterm labor with the oxytocin antagonist atosiban. The Atosiban PTL-098 Study Group.
Valenzuela GJ; Sanchez-Ramos L; Romero R; Silver HM; Koltun WD; Millar L; Hobbins J; Rayburn W; Shangold G; Wang J; Smith J; Creasy GW
Am J Obstet Gynecol; 2000 May; 182(5):1184-90. PubMed ID: 10819856
[TBL] [Abstract][Full Text] [Related]
12. The effects of oxytocin and atosiban on the modulation of heart rate in pregnant women.
Weissman A; Tobia RS; Burke YZ; Maxymovski O; Drugan A
J Matern Fetal Neonatal Med; 2017 Feb; 30(3):329-333. PubMed ID: 27030149
[TBL] [Abstract][Full Text] [Related]
13. Barusiban, a new highly potent and long-acting oxytocin antagonist: pharmacokinetic and pharmacodynamic comparison with atosiban in a cynomolgus monkey model of preterm labor.
Reinheimer TM; Bee WH; Resendez JC; Meyer JK; Haluska GJ; Chellman GJ
J Clin Endocrinol Metab; 2005 Apr; 90(4):2275-81. PubMed ID: 15671092
[TBL] [Abstract][Full Text] [Related]
14. [Clinical experience of using oxytocin antagonist atosiban in the rescue therapy of preterm labour].
Tan JP; Chen H; Du BJ; Liu YL; Wang YH; Zhang JP
Zhonghua Fu Chan Ke Za Zhi; 2008 Feb; 43(2):81-4. PubMed ID: 18683742
[TBL] [Abstract][Full Text] [Related]
15. Tocolysis with atosiban: experience in the management of premature labor before 24 weeks of pregnancy.
Richter ON; Dorn C; van de Vondel P; Ulrich U; Schmolling J
Arch Gynecol Obstet; 2005 Jun; 272(1):26-30. PubMed ID: 15909190
[TBL] [Abstract][Full Text] [Related]
16. Treatment of preterm labor with the oxytocin antagonist atosiban.
Goodwin TM; Valenzuela G; Silver H; Hayashi R; Creasy GW; Lane R
Am J Perinatol; 1996 Apr; 13(3):143-6. PubMed ID: 8688103
[TBL] [Abstract][Full Text] [Related]
17. Adverse and beneficial effects of tocolytic therapy.
Pryde PG; Besinger RE; Gianopoulos JG; Mittendorf R
Semin Perinatol; 2001 Oct; 25(5):316-40. PubMed ID: 11707019
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. The Worldwide Atosiban versus Beta-agonists Study Group.
Worldwide Atosiban versus Beta-agonists Study Group
BJOG; 2001 Feb; 108(2):133-42. PubMed ID: 11236112
[TBL] [Abstract][Full Text] [Related]
19. Atosiban versus betamimetics in the treatment of preterm labour in Germany: an economic evaluation.
Wex J; Connolly M; Rath W
BMC Pregnancy Childbirth; 2009 Jun; 9():23. PubMed ID: 19538754
[TBL] [Abstract][Full Text] [Related]
20. Emerging tocolytics for maintenance therapy of preterm labour: oxytocin antagonists and calcium channel blockers.
Kim A; Shim JY
BJOG; 2006 Dec; 113 Suppl 3():113-5. PubMed ID: 17206978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
